Why is Bafna Pharmaceuticals Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 7.24%
- Poor long term growth as Operating profit has grown by an annual rate -2.00% of over the last 5 years
- NET SALES(Q) Highest at Rs 47.67 cr
- PBDIT(Q) Highest at Rs 8.61 cr.
- OPERATING PROFIT TO NET SALES(Q) Highest at 18.06%
2
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 10-Jun-26 and has generated 179.66% returns since then
- Multiple factors for the stock are Bullish like MACD, Bollinger Band and KST
3
With ROCE of 6.6, it has a Very Expensive valuation with a 8.3 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 175.24%, its profits have risen by 9% ; the PEG ratio of the company is 10.7
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
How much should you hold?
- Overall Portfolio exposure to Bafna Pharma. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Bafna Pharma. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Bafna Pharma.
175.24%
3.37
51.99%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
11.70%
EBIT Growth (5y)
-2.00%
EBIT to Interest (avg)
2.78
Debt to EBITDA (avg)
1.92
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
1.25
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
9.34%
ROCE (avg)
7.97%
ROE (avg)
10.25%
Valuation Key Factors 
Factor
Value
P/E Ratio
97
Industry P/E
40
Price to Book Value
10.78
EV to EBIT
124.68
EV to EBITDA
71.37
EV to Capital Employed
8.26
EV to Sales
7.42
PEG Ratio
10.74
Dividend Yield
NA
ROCE (Latest)
6.62%
ROE (Latest)
11.16%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Technical Movement
10What is working for the Company
NET SALES(Q)
Highest at Rs 47.67 cr
PBDIT(Q)
Highest at Rs 8.61 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 18.06%
PBT LESS OI(Q)
Highest at Rs 5.72 cr.
PAT(Q)
Highest at Rs 6.85 cr.
EPS(Q)
Highest at Rs 2.90
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Bafna Pharma.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 5.72 cr has Grown at 1339.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 0.40 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
Highest at Rs 47.67 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 47.67 cr has Grown at 33.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 35.65 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 8.61 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 18.06%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 5.72 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 6.85 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 2.90
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)